BR9610162A - Compounds use a crystalline salt pharmaceutical composition processes for the preparation of acid addition salts of a compound for the treatment of an indication related to dysfunctions of the D-1 dopamine receptor system in a mammal and for the manufacture of a pharmaceutical composition - Google Patents

Compounds use a crystalline salt pharmaceutical composition processes for the preparation of acid addition salts of a compound for the treatment of an indication related to dysfunctions of the D-1 dopamine receptor system in a mammal and for the manufacture of a pharmaceutical composition

Info

Publication number
BR9610162A
BR9610162A BR9610162A BR9610162A BR9610162A BR 9610162 A BR9610162 A BR 9610162A BR 9610162 A BR9610162 A BR 9610162A BR 9610162 A BR9610162 A BR 9610162A BR 9610162 A BR9610162 A BR 9610162A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
dysfunctions
mammal
manufacture
compound
Prior art date
Application number
BR9610162A
Other languages
Portuguese (pt)
Inventor
Louis Brammer Hansen
Rolf Emil Amsler
Scott Eugene Mcgraw
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR9610162A publication Critical patent/BR9610162A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9610162A 1995-09-15 1996-09-12 Compounds use a crystalline salt pharmaceutical composition processes for the preparation of acid addition salts of a compound for the treatment of an indication related to dysfunctions of the D-1 dopamine receptor system in a mammal and for the manufacture of a pharmaceutical composition BR9610162A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK103095 1995-09-15
PCT/DK1996/000383 WO1997010239A1 (en) 1995-09-15 1996-09-12 Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds

Publications (1)

Publication Number Publication Date
BR9610162A true BR9610162A (en) 1999-01-05

Family

ID=8100205

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9610162A BR9610162A (en) 1995-09-15 1996-09-12 Compounds use a crystalline salt pharmaceutical composition processes for the preparation of acid addition salts of a compound for the treatment of an indication related to dysfunctions of the D-1 dopamine receptor system in a mammal and for the manufacture of a pharmaceutical composition

Country Status (13)

Country Link
EP (1) EP0850237A1 (en)
JP (1) JPH11512403A (en)
KR (1) KR19990044648A (en)
CN (1) CN1200121A (en)
AU (1) AU700596B2 (en)
BR (1) BR9610162A (en)
CA (1) CA2231848A1 (en)
CZ (1) CZ77898A3 (en)
HU (1) HUP9900746A3 (en)
IL (1) IL123602A0 (en)
NO (1) NO981135D0 (en)
PL (1) PL325514A1 (en)
WO (1) WO1997010239A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK23392D0 (en) * 1992-02-24 1992-02-24 Novo Nordisk As Heterocyclic Compounds, Their Uses and Preparation

Also Published As

Publication number Publication date
PL325514A1 (en) 1998-08-03
AU700596B2 (en) 1999-01-07
WO1997010239A1 (en) 1997-03-20
JPH11512403A (en) 1999-10-26
CZ77898A3 (en) 1998-07-15
NO981135L (en) 1998-03-13
CA2231848A1 (en) 1997-03-20
CN1200121A (en) 1998-11-25
KR19990044648A (en) 1999-06-25
MX9802000A (en) 1998-08-30
HUP9900746A2 (en) 1999-09-28
IL123602A0 (en) 1998-10-30
HUP9900746A3 (en) 1999-11-29
AU6923596A (en) 1997-04-01
NO981135D0 (en) 1998-03-13
EP0850237A1 (en) 1998-07-01

Similar Documents

Publication Publication Date Title
ITBO910112A0 (en) GASTRO-RESISTANT PHARMACEUTICAL FORMULATIONS FOR ORAL USE CONTAINING BILE ACIDS SALTS
ITBO910114A0 (en) GASTRO-RESISTANT PHARMACEUTICAL FORMULATIONS WITH CONTROLLED RELEASE FOR ORAL USE CONTAINING BILE ACIDS AND THEIR SALTS
ITMI931324A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING S (+) - 2- (4-ISOBUTYLPHENYL) PROPIONIC SALTS WITH BASIC AMINO ACIDS
IT8820859A0 (en) USE OF GAMMA HYDROXY BUTYRIC ACID SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS SUITABLE FOR BEING USED IN THE THERAPY OF ALCOHOLISM AND RELATED COMPOSITIONS.
EE04614B1 (en) Pharmaceutical preparation for inhalation, use of iprotropium salts and iprotropium salt
EE04463B1 (en) 3-Arylpropanoic acid derivatives and their analogues, process for their preparation, pharmaceutical compositions containing them and compounds for use in therapy
ITBO910113A0 (en) CASTRO-RESISTANT PHARMACEUTICAL FORMULATIONS FOR ORAL USE CONTAINING BILE ACIDS
IT1207994B (en) WATER SOLUBLE SALTS OF ANTI-INFLAMMATORY AND ANALGESIC ADAPTITY COMPOUNDS, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS.
BR0012082A (en) Pharmaceutical formulation for administration comprising morphine and its use
DK414389D0 (en) PHARMACEUTICAL PREPARATION CONTAINING AN AMINO ACID DERIVATIVE WITH PURINE-INHIBITORIAL EFFECT
IT9021662A0 (en) PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE INCLUDING SODIUM HYLUROMICOSAL ACID AND DISINFECTANT SUBSTANCES
ATE314862T1 (en) GEL-TYPE PHARMACEUTICAL COMPOSITION FOR SUBCUTANE USE CONTAINING BISPHOSPHONIC ACIDS OR SALTS THEREOF
ITMI941262A0 (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING (S)-2-(4- ISOBUTYLPHENYL) PROPIONIC ACID AS THE ACTIVE INGREDIENT
ATE241987T1 (en) DILTIAZEM COMPOSITIONS WITH CONTROLLED ACTIVE ABSORPTION
BR9610733A (en) Compound processes for the preparation of it and for the treatment of a mammal pharmaceutical composition and use of a compound
IT1232303B (en) DIAMINE COMPOUNDS AND THEIR SALTS, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND THEIR SA LI
CA2170485A1 (en) Compositions Containing an Amino Acid Salt of Propionic Acid Non-Steroidal Anti-Inflammatory Agents and Caffeine
BR9610162A (en) Compounds use a crystalline salt pharmaceutical composition processes for the preparation of acid addition salts of a compound for the treatment of an indication related to dysfunctions of the D-1 dopamine receptor system in a mammal and for the manufacture of a pharmaceutical composition
KR900009557A (en) Preparation of amino acid methyl ester inorganic acid salt
BR9610388A (en) Pyrimidine compound or an acid addition salt thereof for the preparation of a pyrimidine and pharmaceutical formulation
IT1229563B (en) SALT TYPE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCEDURE FOR THEIR PREPARATION.
ITMI911059A1 (en) METHYLTAUROUROXODESOXICOLIC ACID AND ITS THERAPEUTICALLY ACTIVE DERIVATIVES PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
IT1147001B (en) OXYIMIDAZO DERIVATIVES KINOXALINE AND THEIR SALTS, PROCEDURE FOR THEIR PREPARATION, THEIR USE AS MEDICATIONS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
BRPI0115076B8 (en) pharmaceutical preparation, its pharmaceutical application, as well as the process for its preparation
BR0008479A (en) 5-ht 1f agonists

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]